Meet the Expert
dMMR and MSI testing
in Endometrial cancer
Tuesday, September 24th, 2024
16:00 – 18:00 (CEST), virtual
Host:
Prof. Dr. med. Hans-Ulrich SchildhausProf. Dr. med. Josef Rüschoff
Speaker:
Prof. Dr. med. Reinhard BuettnerProf. Dr. med. Frédérique Penault-Llorca
Prof. Dr. med. Josef Rueschoff
Dear colleagues,
Endometrial cancer represents about 90% of all uterine cancers, and approximately 11,000 women are diagnosed with it each year in Germany alone and about 30% of all affected patients exhibit Microsatellite Instability (MSI). Given these numbers, we see an urgent need for accurate testing and diagnosis of potential Microsatellite Instability in all patients to ensure appropriate treatment. Our webinar aims to provide diagnostic laboratories and physicians across Europe with the opportunity to improve the quality of dMMR/MSI testing by standardizing the evaluation process. Only through reliable and comparable diagnostics patients can benefit from new treatment options, such as immune checkpoint inhibitors.
Contact us
If questions should arise or you encounter any issues with the registration, please contact us via email to [email protected] .
Sponsor
Privacy and Data Protection
You can contact us at any time if you have further questions about the issue of privacy and data protection by emailing our Global Privacy Officer at [email protected] or our external data protection officer:Dr. Barbara Tomasi
MyData-TRUST
[email protected]
Phone: +49 32 212296564
We assure that the contents of the webinar are designed to be product- and service-neutral. We assure that potential conflicts of interest of the organizer, the scientific management, and the speakers are disclosed to the participants in a self-declaration (e.g., first slide of presentations, handouts, notices, information in the program, link or download). The event (September 24th, 2024) is sponsored by GlaxoSmithKline with €45,600.00. The total expenses for the event amount to €45,600.00.